Cara Therapeutics | Aktywa





Aktywa Zmiana Data
Acadia Pharmaceuticals USD 1.33B 105.22M 2025-09
Alterity Therapeutics Limited AUD 27.32M 6.07M 2023-06
Assertio Holdings USD 319.77M 46M 2025-09
Cara Therapeutics USD 43.75M 4.8M 2025-06
Cassava Sciences USD 129.73M 5.65M 2025-09
Chugai Pharma JPY 2.47T 285.01B 2025-12
Cipla INR 401.64B 27.77B 2025-09
Clal Biotechnology ILS 158.39M 24.3M 2023-12
Compugen USD 97.84M 8.68M 2025-09
CSL USD 39.4B 957M 2025-06
Grifols EUR 23.29B 3.35M 2025-09
Halozyme Therapeutics USD 2.22B 167.33M 2025-09
J&J USD 192.82B 573M 2025-09
Neurocrine Biosciences USD 4.27B 375.9M 2025-09
Pacira USD 1.3B 239.68M 2025-09
Pfizer USD 208.73B 2.64B 2025-09
RedHill Biopharma USD 18.38M 332K 2025-06
Supernus Pharmaceuticals USD 1.42B 37.35M 2025-09
Vanda Pharmaceuticals USD 601.14M 23.61M 2025-09


Cara Therapeutics Aktywa - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Feb 2026.